1. Home
  2. COAG vs KARO Comparison

COAG vs KARO Comparison

Compare COAG & KARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hemab Therapeutics Holdings Inc. Common Stock

COAG

Hemab Therapeutics Holdings Inc. Common Stock

N/A

Current Price

$44.41

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

KARO

Karooooo Ltd.

HOLD

Current Price

$65.48

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
COAG
KARO
Founded
N/A
2001
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
COAG
KARO
Price
$44.41
$65.48
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$59.33
AVG Volume (30 Days)
276.2K
54.7K
Earning Date
N/A
05-15-2026
Dividend Yield
N/A
2.52%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$22.17
Revenue Next Year
N/A
$16.74
P/E Ratio
N/A
$24.13
Revenue Growth
N/A
N/A
52 Week Low
$27.47
$41.25
52 Week High
$55.42
$68.80

Technical Indicators

Market Signals
Indicator
COAG
KARO
Relative Strength Index (RSI) 43.32 60.09
Support Level $42.65 $60.87
Resistance Level $53.01 $66.67
Average True Range (ATR) 3.78 1.79
MACD -1.12 -0.04
Stochastic Oscillator 13.12 70.66

Price Performance

Historical Comparison
COAG
KARO

About COAG Hemab Therapeutics Holdings Inc. Common Stock

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

About KARO Karooooo Ltd.

Karooooo Ltd is a provider of an operational intelligence platform. Through its cloud platform, the company enables fleet and asset management, fuel management, workforce management, logistics, safety, including AI-assisted video safety, compliance, risk, and environmental impact management. Its segments are: Cartrack, which generates the majority of revenue, provides an operational intelligence platform that maximizes the value of transportation, operations, and workflow data through insightful real-time data analytics to connected vehicles and equipment, and Karooooo Logistics provides a software application enabling the management of last-mile B2B delivery and general operational logistics (Delivery-as-a-Service or DaaS). It generates the majority of its revenue from South Africa.

Share on Social Networks: